Elyxyb (Celecoxib Oral Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 13, 2020 Category: Drugs & Pharmacology Source Type: news
FDA Approves Elyxyb (celecoxib) Oral Solution For Acute Treatment Of Migraine With Or Without Aura In Adults
HYDERABAD, India& PRINCETON, N.J.--(BUSINESS WIRE) May 06, 2020 --Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as“Dr. Reddy’s”) today announced approval of Elyxyb (celecoxib oral... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 5, 2020 Category: Drugs & Pharmacology Source Type: news
Mesothelioma Gene Therapy Trial Shows ‘Real Potential’
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial.
The phase III trial, known as the INFINITE clinical research study, is designed to evaluate the intrapleural delivery of an investigational drug — a type of gene therapy — in combination with celecoxib and gemcitabine, anti-inflammatory and chemotherapy drugs, respectively.
Researchers hope to stop, or at least slow, the growth of mesothelioma tumor cells with the combination therapy.
“This is a very interesting concept,” oncologist Dr. Bernardo Goulart of the Se...
Source: Asbestos and Mesothelioma News - February 17, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news
Gene Therapy for Mesothelioma Has ‘Real Potential’
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial.
The phase III trial, known as the INFINITE clinical research study, is designed to evaluate the intrapleural delivery of an investigational drug — a type of gene therapy — in combination with celecoxib and gemcitabine, anti-inflammatory and chemotherapy drugs, respectively.
Researchers hope to stop, or at least slow, the growth of mesothelioma tumor cells with the combination therapy.
“This is a very interesting concept,” oncologist Dr. Bernardo Goulart of the Se...
Source: Asbestos and Mesothelioma News - February 17, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news
Celecoxib Added to Concurrent Chemoradiation Not Effective for Patients with NSCLC
Although concurrent chemotherapy and radiation is considered standard care, treatment of locally advanced NSCLC continues to be challenging, leading researchers to search for patients who may benefit from the addition of cyclooxygenase 2 inhibitors. (Source: CancerNetwork)
Source: CancerNetwork - January 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Health Tip: Taking Anti-Inflammatory Drugs
-- Pain relievers like ibuprofen, naproxen and celecoxib are popular anti-inflammatory drugs for back pain, headache and other aches and pains.
Though these drugs have a good safety history, the risk of serious side effects rises when the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 23, 2019 Category: General Medicine Source Type: news
Mesothelioma Clinical Trial Targets Latest Gene Therapy
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer.
The payoff may have finally arrived.
Albelda and Sterman’s long-awaited, phase III clinical trial will open this month to evaluate the efficacy of TR002, a novel gene therapy drug, when used in combination with celecoxib and gemcitabine.
TR002, a form of immunotherapy, is a genetically engineered adenovirus that triggers the anti-tumor effects of interferon, a naturally occurring protein that destroys cancer cells.
“The hope is, if it works ...
Source: Asbestos and Mesothelioma News - September 4, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Medical News Today: Study ties arthritis pain reliever to heart valve disease
An analysis of 8,600 electronic medical records has found a specific link between the use of the NSAID celecoxib (Celebrex) and aortic stenosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 26, 2019 Category: Consumer Health News Tags: Osteoarthritis Source Type: news
Study links Celebrex, heart valve calcification after earlier research declared drug safe
A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification - commonly called NSAIDs. Now, a big-data analysis of patient records at Vanderbilt University has found a link specifically between Celebrex and heart valve calcification. (Source: World Pharma News)
Source: World Pharma News - February 22, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Study links Celebrex, heart valve calcification after earlier research declared drug safe
(Vanderbilt University) On National Heart Valve Disease Awareness Day, Vanderbilt study disputes that Celebrex has no more impact on valves than older drugs in its class. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2019 Category: International Medicine & Public Health Source Type: news
Outcomes With Celecoxib and Aspirin in AI-Treated Patients Outcomes With Celecoxib and Aspirin in AI-Treated Patients
Does short-term celecoxib or low-dose aspirin use decrease risk of breast cancer recurrence?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
celecoxib (Celebrex)
Title: celecoxib (Celebrex)Category: MedicationsCreated: 2/11/1999 12:00:00 AMLast Editorial Review: 9/12/2018 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 12, 2018 Category: Rheumatology Source Type: news
Obesity and inflammation -- A deadly combination for prostate cancer
(Osaka University) A new Osaka-centered study identified the mechanisms of high-fat diet (HFD)-induced prostate cancer progression. They observed in a mouse model that HFD accelerated tumor growth and increased the myeloid-derived suppressor cells fraction and M2/M1 macrophage ratio. Additionally, the anti-inflammatory drug celecoxib suppressed tumor growth. Their results suggest that HFD-induced prostate cancer growth via cytokine IL6 signaling could also exist in obese humans, and celecoxib may have clinical benefits for obese patients with prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 17, 2018 Category: Cancer & Oncology Source Type: news
Concensi (Amlodipine and Celecoxib Tablet) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 8, 2018 Category: Drugs & Pharmacology Source Type: news
FDA OKs Consensi for Osteoarthritis Pain and Hypertension FDA OKs Consensi for Osteoarthritis Pain and Hypertension
The FDA has approved a combination of amlodipine besylate and celecoxib (Consensi, Kitov Pharma) for individuals with osteoarthritis pain and hypertension.FDA Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 1, 2018 Category: Internal Medicine Tags: Rheumatology News Alert Source Type: news
